Takotsubo cardiomyopathy following liver transplantation and COVID-19 infection

Evan Winrich; Agastya D Belur; Amal Shine; Loretta L Jophlin

doi:10.1080/08998280.2022.2114069

Takotsubo cardiomyopathy following liver transplantation and COVID-19 infection

Proc (Bayl Univ Med Cent). 2022 Aug 23;36(1):99-100. doi: 10.1080/08998280.2022.2114069. eCollection 2023.

Authors

Evan Winrich¹, Agastya D Belur^{1

2}, Amal Shine^{1

3}, Loretta L Jophlin^{1

3}

Affiliations

¹ Department of Medicine, School of Medicine, University of Louisville, Louisville, Kentucky.
² Division of Cardiovascular Medicine, University of Louisville, Louisville, Kentucky.
³ Division of Gastroenterology, Hepatology, and Nutrition, University of Louisville, Louisville, Kentucky.

Abstract

Takotsubo cardiomyopathy involves transient systolic dysfunction of the left ventricle thought to be caused by a physiologic stress response and associated catecholamine release. We present a previously undocumented cause of this stress response involving a 53-year-old man with hepatocellular carcinoma and alcohol-associated cirrhosis who initially presented for liver transplantation. Shortly after successful transplantation, the patient developed a COVID-19 infection and takotsubo cardiomyopathy.

Keywords: Liver transplant; takotsubo cardiomyopathy.

Publication types

Case Reports

Grants and funding

K08 DK123381/DK/NIDDK NIH HHS/United States